RBC Capital Markets upgraded shares of KP Tissue Inc (TSE:KPT) from a sector perform rating to an outperform rating in a research note published on Monday morning. They currently have C$17.00 target price on the stock, up from their previous target price of C$15.00.

KPT has been the subject of several other research reports. Desjardins upgraded shares of KP Tissue from a hold rating to a buy rating and raised their target price for the stock from C$13.50 to C$15.00 in a report on Thursday, August 11th. Scotiabank upgraded shares of KP Tissue from a sector perform rating to an outperform rating and raised their target price for the stock from C$14.00 to C$16.50 in a report on Thursday, August 11th. TD Securities restated a buy rating and issued a C$15.00 target price on shares of KP Tissue in a report on Thursday, August 11th. CIBC raised their target price on shares of KP Tissue from C$15.00 to C$16.00 in a report on Friday, August 12th. Finally, Royal Bank Of Canada raised their target price on shares of KP Tissue from C$13.00 to C$15.00 and gave the stock a sector perform rating in a report on Friday, November 4th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of Buy and an average price target of C$16.21.

Analyst Recommendations for KP Tissue (TSE:KPT)

KP Tissue (TSE:KPT) opened at 14.80 on Monday. KP Tissue has a 52-week low of $9.70 and a 52-week high of $14.84. The firm has a 50 day moving average of $14.24 and a 200-day moving average of $13.41. The stock’s market cap is $134.55 million.

WARNING: “KP Tissue Inc (KPT) Upgraded to Outperform by RBC Capital Markets” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/29/kp-tissue-inc-kpt-upgraded-to-outperform-by-rbc-capital-markets.html.

About KP Tissue

KP Tissue Inc is created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom tissue, facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.

Receive News & Stock Ratings for KP Tissue Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue Inc and related stocks with our FREE daily email newsletter.